Expert Review of Anticancer Therapy, Volume 20, Issue 3 (2020)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Anticancer Therapy, Volume 20, Issue 3 (2020)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Volume 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
The addition of apalutamide to ADT in the treatment of metastatic castration-sensitive prostate cancer: safety and efficacy
Pedro Barata, Umang Swami & Neeraj Agarwal
Pages: 147-150
Published online: 24 Feb 2020
First Page PreviewforThe addition of apalutamide to ADT in the treatment of metastatic castration-sensitive prostate cancer: safety and efficacy | Full Text | References | PDF (384.5 KB) | EPUB
  • 1867 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Article
Atezolizumab for the treatment of breast cancer
Sangeetha M. Reddy, Emma Carroll & Rita Nanda
Pages: 151-158
Published online: 27 Feb 2020
AbstractforAtezolizumab for the treatment of breast cancer | Full Text | References | PDF (848.5 KB) | EPUB
  • 1466 Views
  • 41 CrossRef citations
  • 0Altmetric

Review

Review
Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients
Giacomo Montagna & Monica Morrow
Pages: 159-166
Published online: 28 Feb 2020
AbstractforContralateral prophylactic mastectomy in breast cancer: what to discuss with patients | Full Text | References | PDF (909.5 KB) | EPUB
  • 350 Views
  • 15 CrossRef citations
  • 0Altmetric
Review
Advancements in predicting outcomes in patients with glioma: a surgical perspective
Asgeir Store Jakola, Lisa Millgård Sagberg, Sasha Gulati & Ole Solheim
Pages: 167-177
Published online: 02 Mar 2020
AbstractforAdvancements in predicting outcomes in patients with glioma: a surgical perspective | Full Text | References | PDF (1.3 MB) | EPUB
  • 2957 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access
Review
Bladder-sparing treatment options in localized muscle-invasive bladder cancer
Gregory J Nason, Khaled Ajib, Guan H Tan & Girish S Kulkarni
Pages: 179-188
Published online: 09 Mar 2020
AbstractforBladder-sparing treatment options in localized muscle-invasive bladder cancer | Full Text | References | PDF (774.5 KB) | EPUB
  • 377 Views
  • 6 CrossRef citations
  • 0Altmetric
Review
Further insights into testicular germ cell tumor oncogenesis: potential therapeutic targets
Paolo Chieffi, Marco De Martino & Francesco Esposito
Pages: 189-195
Published online: 12 Mar 2020
AbstractforFurther insights into testicular germ cell tumor oncogenesis: potential therapeutic targets | Full Text | References | PDF (686.2 KB) | EPUB
  • 247 Views
  • 6 CrossRef citations
  • 0Altmetric
Review
The controversial role of Bevacizumab in the treatment of patients with intracranial meningioma: a comprehensive literature review
Alba Scerrati, Lorenzo Mongardi, Jacopo Visani, Giorgio Lofrese, Michele Alessandro Cavallo, Alba Fiorentino & Pasquale De Bonis
Pages: 197-203
Published online: 06 Mar 2020
AbstractforThe controversial role of Bevacizumab in the treatment of patients with intracranial meningioma: a comprehensive literature review | Full Text | References | PDF (578.3 KB) | EPUB
  • 237 Views
  • 10 CrossRef citations
  • 0Altmetric
Review
Pitfalls and controversies in pathology impacting breast cancer management
Woo Gyeong Kim, Margaret C. Cummings & Sunil R. Lakhani
Pages: 205-219
Published online: 14 Mar 2020
AbstractforPitfalls and controversies in pathology impacting breast cancer management | Full Text | References | PDF (2.3 MB) | EPUB
  • 275 Views
  • 3 CrossRef citations
  • 0Altmetric
Review
Treatment options after first-line immunotherapy in metastatic NSCLC
Edgardo S. Santos
Pages: 221-228
Published online: 12 Mar 2020
AbstractforTreatment options after first-line immunotherapy in metastatic NSCLC | Full Text | References | PDF (646.2 KB) | EPUB
  • 552 Views
  • 6 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Elevated DKK1 expression: a promising prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma
Waseem Jerjes
Letter to the Editor | Published online: 15 Jul 2024
Free Access
The new life of ibrutinib therapy in CLL: enhancing personalized approaches
Stefano Molica et al.
Editorial | Published online: 15 Jul 2024
Free Access
Immune-related adverse events associated with Mogamulizumab: a comprehensive review of the literature
Genevieve S. Silva et al.
Review Article | Published online: 11 Jul 2024
First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLC
Pierre Peterlin et al.
Article | Published online: 10 Jul 2024
Open Access
View all latest articles